In order to provide a novel cancer treatment method using a FTD·TPI combination drug that exhibits markedly excellent anti-tumor effects with fewer side effects, the present invention provides an anti-tumor agent characterized in that the FTD·TPI combination drug and a taxane compound are administered in combination.